Caliper, Monogram Removed from Nasdaq Biotech Index

Caliper and Monogram were among 16 firms removed from the Nasdaq Biotech index as part of its semi-annual re-ranking of biotech firms.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.